Poly‐gene fusion transcripts and chromothripsis in prostate cancer
暂无分享,去创建一个
Yongjun Zhao | Chunxiao Wu | Dong Lin | Andrew McPherson | A. Lapuk | S. C. Sahinalp | C. Collins | S. Volik | M. Marra | Yongjun Zhao | M. Gleave | Chunxiao Wu | A. Wyatt | A. McPherson | B. McConeghy | Fan Mo | R. Shukin | Yuzhuo Wang | D. Lin | Fan Mo | Robert Shukin | Yuzhuo Wang | Alexander W. Wyatt | Brian J. McConeghy | Anna V. Lapuk | Steven J. M. Jones | Marco A. Marra | Martin E. Gleave | Stanislav V. Volik | S. Cenk Sahinalp | Colin C. Collins | Steven J. M. Jones
[1] C. Cooper,et al. ETS gene fusions in prostate cancer , 2009, Nature Reviews Urology.
[2] Steven J. M. Jones,et al. Circos: an information aesthetic for comparative genomics. , 2009, Genome research.
[3] M. Hegde,et al. Multiple tumors in a child with germ-line mutations in TP53 and PTEN. , 2008, The New England journal of medicine.
[4] F. Hormozdiari,et al. Comrad : a novel algorithmic framework for the integrated analysis of RNA-Seq and WGSS data , 2011 .
[5] V. Daggett,et al. Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain. , 2011, Biochemistry.
[6] Rafael J. Yáñez-Muñoz,et al. Chromosome rearrangement associated inactivation of tumour suppressor genes in prostate cancer. , 2011, American journal of cancer research.
[7] Benjamin J. Raphael,et al. Decoding the fine-scale structure of a breast cancer genome and transcriptome. , 2006, Genome research.
[8] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[9] Ryan D. Morin,et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.
[10] R. Wilson,et al. Chromothripsis and Human Disease: Piecing Together the Shattering Process , 2012, Cell.
[11] David E. Williams,et al. Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. , 2010, Cancer cell.
[12] R. Shah,et al. Role of the TMPRSS2-ERG gene fusion in prostate cancer. , 2008, Neoplasia.
[13] S. C. Sahinalp,et al. nFuse: Discovery of complex genomic rearrangements in cancer using high-throughput sequencing , 2012, Genome research.
[14] Kiran C. Bobba,et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.
[15] S. Henikoff,et al. Predicting deleterious amino acid substitutions. , 2001, Genome research.
[16] N. Carter,et al. Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.
[17] J. Tchinda,et al. Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer , 2005, Science.
[18] C. Sander,et al. Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.
[19] Lior Pachter,et al. Sequence Analysis , 2020, Definitions.
[20] Markus J. van Roosmalen,et al. Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline. , 2011, Human molecular genetics.
[21] S. Smith,et al. Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Cuzick,et al. Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer , 2008, British Journal of Cancer.
[23] S. Luo,et al. Chimeric transcript discovery by paired-end transcriptome sequencing , 2009, Proceedings of the National Academy of Sciences.
[24] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[25] M. Olivier,et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database , 2007, Human mutation.
[26] Markus J. van Roosmalen,et al. Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer , 2011, Genome Biology.
[27] Eric S. Lander,et al. The genomic complexity of primary human prostate cancer , 2010, Nature.
[28] Stephen J. Salipante,et al. Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers , 2011, Proceedings of the National Academy of Sciences.
[29] S. Dhanasekaran,et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer , 2007, Nature.
[30] David T. W. Jones,et al. Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations , 2012, Cell.
[31] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[32] K. Chin,et al. End-sequence profiling: Sequence-based analysis of aberrant genomes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[33] A. Børresen-Dale,et al. COMPLEX LANDSCAPES OF SOMATIC REARRANGEMENT IN HUMAN BREAST CANCER GENOMES , 2009, Nature.
[34] N. Munshi,et al. Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients. , 2011, Blood.
[35] Faraz Hach,et al. Comrad: detection of expressed rearrangements by integrated analysis of RNA-Seq and low coverage genome sequence data , 2011, Bioinform..
[36] A. Chinnaiyan,et al. The emergence of lncRNAs in cancer biology. , 2011, Cancer discovery.
[37] S. Kato,et al. Understanding the function–structure and function–mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[38] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[39] Robert H. Bell,et al. From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer , 2012, The Journal of pathology.
[40] M. Gleave,et al. MicroRNAs Associated with Metastatic Prostate Cancer , 2011, PloS one.
[41] A. Gonzalez-Perez,et al. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.
[42] P. Stankiewicz,et al. Chromosome Catastrophes Involve Replication Mechanisms Generating Complex Genomic Rearrangements , 2011, Cell.
[43] Lee T. Sam,et al. Transcriptome Sequencing to Detect Gene Fusions in Cancer , 2009, Nature.
[44] Süleyman Cenk Sahinalp,et al. deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data , 2011, PLoS Comput. Biol..
[45] Laurence H. Pearl,et al. Structure and function of the Rad9-binding region of the DNA-damage checkpoint adaptor TopBP1 , 2010, Nucleic Acids Res..
[46] M. Eilers,et al. Fbw7 and Usp28 Regulate Myc Protein Stability in Response to DNA Damage , 2007, Cell cycle.
[47] Francesca Demichelis,et al. Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. , 2011, Genome research.
[48] Richard Durbin,et al. Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..
[49] Wei Yan,et al. Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. , 2011, Cancer cell.
[50] Steven J. M. Jones,et al. Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer , 2012, The Journal of pathology.
[51] P. Pandolfi,et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010, Nature.